Rare Disease Day 2026: Advancing Care Through Innovation, Multidisciplinary Expertise, and Emerging Therapies

Observed annually on February 28, Rare Disease Day highlights the clinical, scientific, and policy challenges associated with conditions that individually affect small patient populations but collectively impact millions worldwide. For clinicians, rare diseases often require heightened diagnostic vigilance, familiarity with evolving therapeutic landscapes, and coordinated multidisciplinary management.

In observance of Rare Disease Day, Consultant360 features a curated series of expert interviews and case-based discussions focused on neuromyelitis optica spectrum disorder, Danon disease, acute hepatic porphyria, pulmonary arterial hypertension, and nephropathic cystinosis. These segments examine contemporary management challenges, advances in gene and targeted therapies, recent FDA approvals, and evidence-informed strategies aimed at improving outcomes in patients with rare, high-complexity disorders.

©2026 HMP Global. All Rights Reserved. Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.